APOLLO HOSPITALS ENTER. L vs AUROBINDO PHARMA LTD

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and AUROBINDO PHARMA LTD (AUROPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, AUROBINDO PHARMA LTD leads APOLLOHOSP vs AUROPHARMA on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
25.41
13.42
P/B ratio
2.39
0.11%
Dividend yield
0.25%
₹135.04
EPS
₹60.34

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
10.10%
18.00%
Return on capital
13.00%
15.00%
EBITDA margin
20.00%
7.94%
Net margin
10.41%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
10.63%
33.39%
Profit CAGR (3Y)
22.02%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹89,061 Cr
₹25,228 Cr
Revenue
₹33,653 Cr
₹2,003 Cr
Net profit
₹3,503 Cr
0.90
Debt / equity
0.21
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
AUROBINDO PHARMA LTD
  • ["The company has delivered a poor sales growth of 6.32% over past five years.", "Company has a low return on equity of 10.8% over last 3 years.", "Company might be capitalizing the interest cost"]
APOLLO HOSPITALS ENTER. L full analysis AUROBINDO PHARMA LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLO HOSPITALS ENTER. L vs AUROBINDO PHARMA LTD: Share Price, Valuation & Which to Buy | DocStoX